Frontiers in Pharmacology (Aug 2022)

Therapeutic targets by traditional Chinese medicine for ischemia-reperfusion injury induced apoptosis on cardiovascular and cerebrovascular diseases

  • Xiuli Cheng,
  • Jin Hu,
  • Xiaofeng Liu,
  • Jonnea Japhet Tibenda,
  • Xiaobo Wang,
  • Qipeng Zhao,
  • Qipeng Zhao

DOI
https://doi.org/10.3389/fphar.2022.934256
Journal volume & issue
Vol. 13

Abstract

Read online

Traditional Chinese medicine (TCM) has a significant role in treating and preventing human diseases. Ischemic heart and cerebrovascular injuries are two types of diseases with different clinical manifestations with high prevalence and incidence. In recent years, it has been reported that many TCM has beneficial effects on ischemic diseases through the inhibition of apoptosis, which is the key target to treat myocardial and cerebral ischemia. This review provides a comprehensive summary of the mechanisms of various TCMs in treating ischemic cardiovascular and cerebrovascular diseases through anti-apoptotic targets and pathways. However, clinical investigations into elucidating the pharmacodynamic ingredients of TCM are still lacking, which should be further demystified in the future. Overall, the inhibition of apoptosis by TCM may be an effective strategy for treating ischemic cardio-cerebrovascular diseases.

Keywords